Increased retention of intrauterine contraceptive devices medicated with indomethacin and medroxyprogesterone acetate.
作者信息
Von Dadelszen P, Hurst P R, Peplow P V
出版信息
Proc Univ Otago Med Sch. 1981 Oct;59(3):101-3.
PMID:12264137
Abstract
摘要
相似文献
1
Increased retention of intrauterine contraceptive devices medicated with indomethacin and medroxyprogesterone acetate.
Proc Univ Otago Med Sch. 1981 Oct;59(3):101-3.
2
Fertility regulation technology: status and prospects.
Popul Bull. 1977 Mar;31(6):1-25.
3
[The effect of intrauterine contraceptive devices on the endometrium].
Contracept Fertil Sex (Paris). 1987 Nov;15(11):1015-24.
4
Comprehensive overview of intrauterine contraceptive device (IUCD).
J Obstet Gynaecol East Cent Africa. 1983 Sep;2(3):91-6.
5
[Injectable contraceptive: nuclear effects after use].
J Bras Ginecol. 1986 Aug;96(8):391-7.
6
[Preclinical research and development of norethisterone].
Contracept Fertil Sex (Paris). 1985 Jan;13(1 Suppl):437-44.
7
8
Intrauterine release of progesterone: changes in RNA patterns of endometrium.
Contracept Deliv Syst. 1981 Jul;2(3):219-23.
9
Corpus luteum function in medicated and non-medicated IUD users.
Contracept Deliv Syst. 1983 Jul;4(3):163-7.
10
Intracervical device may be effective hormonal contraceptive.
Contracept Technol Update. 1988 Jul;9(7):81-3.
Zotero 插件